Hydrogen sulphide: A novel physiological inhibitor of LDL atherogenic modification by HOCl

Author: Laggner Hilde   Muellner Markus K.   Schreier Sabine   Sturm Brigitte   Hermann Marcela   Exner Markus   Gmeiner Bernhard M. K.   Kapiotis Stylianos  

Publisher: Informa Healthcare

ISSN: 1071-5762

Source: Free Radical Research, Vol.41, Iss.7, 2007-01, pp. : 741-747

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content